Nielsen Kirk G. — SEC insider filings
SEC reporting owner CIK 1523522. 31 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2020-11-19 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 19 legs across 10 filings — 778,303 shares, $7,991,703 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 206 shares, $24,720 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 68.
- Largest priced transaction: purchase of 165,000 shares @ $16.00 ($2,640,000) in SpyGlass Pharma, Inc., filed 2026-02-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | Director | 5 | 2 legs · 330,000 sh · $5,280,000 | — | 24 |
| CVRx, Inc. (CVRX) | Director | 16 | 17 legs · 448,303 sh · $2,711,703 | — | 10 |
| Inari Medical, Inc. (NARI) | Director | 10 | — | 1 leg · 206 sh · $24,720 | 34 |
Insider filings — Nielsen Kirk G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | SpyGlass Pharma, Inc. (SGP) | Other (J): 331,036 @ $0 · Other (J): 8,646 @ $0 · Other (J): 8,634 @ $0 | EDGAR |
| 2026-06-03 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 8,720 @ $0 · Grant/award (A): 11,182 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4/A | SpyGlass Pharma, Inc. (SGP) | Conversion (C): 1,690,230 (derivative) · Conversion (C): 548,067 (derivative) · Conversion (C): 548,067 (derivative) · Conversion (C): 359,255 (derivative) | EDGAR |
| 2026-02-10 | 4 | SpyGlass Pharma, Inc. (SGP) jointly with Vensana Capital I GP, LLC, Vensana Capital I, L.P., Klein Peter Justin | Conversion (C): 1,690,230 · Conversion (C): 548,067 · Conversion (C): 548,067 · Conversion (C): 359,255 · Purchase (P): 165,000 @ $16 · Conversion (C): 9,689,922 (derivative) · +3 more | EDGAR |
| 2026-02-10 | 4 | SpyGlass Pharma, Inc. (SGP) | Conversion (C): 1,690,230 · Conversion (C): 548,067 · Conversion (C): 548,067 · Conversion (C): 359,255 · Purchase (P): 165,000 @ $16 · Conversion (C): 9,689,922 (derivative) · +3 more | EDGAR |
| 2026-02-09 | 4 | SpyGlass Pharma, Inc. (SGP) | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 19,554 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 10,966 @ $5.45 | EDGAR |
| 2025-05-14 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 25,200 @ $4.79 · Purchase (P): 101,413 @ $5.29 · Purchase (P): 61,200 @ $5.23 | EDGAR |
| 2024-06-07 | 4/A | CVRx, Inc. (CVRX) | Grant/award (A): 27,250 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 20,961 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 12,012 (derivative) @ $0 | EDGAR |
| 2023-05-30 | 4 | Inari Medical, Inc. (NARI) | Option exercise (M): 2,982 @ $0 · Option exercise (M): 2,982 (derivative) @ $0 | EDGAR |
| 2023-05-22 | 4 | Inari Medical, Inc. (NARI) | Grant/award (A): 2,412 @ $0 | EDGAR |
| 2022-06-09 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 26,985 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Inari Medical, Inc. (NARI) | Grant/award (A): 2,420 @ $0 · Option exercise (M): 2,983 @ $0 · Option exercise (M): 2,983 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 8,070 @ $5.05 | EDGAR |
| 2022-05-23 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 10,976 @ $5.04 · Purchase (P): 13,387 @ $5.04 · Purchase (P): 4,432 @ $5.04 | EDGAR |
| 2022-05-05 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 32,809 @ $6.00 · Purchase (P): 25,503 @ $5.99 · Purchase (P): 3,992 @ $6.00 | EDGAR |
| 2022-05-02 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 100 @ $5.97 · Purchase (P): 41,988 @ $5.97 | EDGAR |
| 2022-02-28 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 3,400 @ $8.24 | EDGAR |
| 2022-02-23 | 4 | CVRx, Inc. (CVRX) | Purchase (P): 26,659 @ $7.92 · Purchase (P): 40,008 @ $7.94 · Purchase (P): 38,200 @ $8.04 | EDGAR |
| 2021-07-02 | 4 | CVRx, Inc. (CVRX) | Conversion (C): 1,461,831 · Conversion (C): 23,125,000 (derivative) @ $0 | EDGAR |
| 2021-07-01 | 4 | CVRx, Inc. (CVRX) | Grant/award (A): 10,382 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4/A | Inari Medical, Inc. (NARI) | Holdings only — no transactions reported | EDGAR |
| 2021-05-28 | 4 | Inari Medical, Inc. (NARI) | Option exercise (M): 2,982 @ $0 · Grant/award (A): 1,380 @ $0 · Option exercise (M): 2,982 (derivative) @ $0 | EDGAR |
| 2021-03-15 | 4 | Inari Medical, Inc. (NARI) | Other (J): 570,957 @ $0 · Other (J): 147,021 @ $0 · Other (J): 147,021 @ $0 · Other (J): 7,955 @ $0 · Other (J): 3,596 @ $0 · Sale (S): 206 @ $120 | EDGAR |
| 2021-01-15 | 4 | Inari Medical, Inc. (NARI) | Other (J): 856,437 @ $0 · Other (J): 220,532 @ $0 · Other (J): 220,532 @ $0 · Other (J): 11,933 @ $0 · Other (J): 5,395 @ $0 | EDGAR |
| 2021-01-06 | 4 | Inari Medical, Inc. (NARI) | Other (J): 856,437 @ $0 · Other (J): 220,530 @ $0 · Other (J): 220,530 @ $0 · Other (J): 11,932 @ $0 · Other (J): 5,395 @ $0 | EDGAR |
| 2020-12-04 | 4 | Inari Medical, Inc. (NARI) | Other (J): 421,331 @ $0 · Other (J): 108,490 @ $0 · Other (J): 108,490 @ $0 · Other (J): 5,869 @ $0 · Other (J): 2,654 @ $0 | EDGAR |
| 2020-11-19 | 4 | Inari Medical, Inc. (NARI) | Other (J): 3,004,415 @ $0 · Other (J): 164,825 @ $0 · Other (J): 164,825 @ $0 · Other (J): 18,925 @ $0 · Other (J): 8,837 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1523522 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs